American Oncology Network, Inc. financial data

Symbol
AONC, AONCW on OTC
Location
Fort Myers, FL
Fiscal year end
31 December
Latest financial report
10-K - Q4 2024 - 27 Mar 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 140% % -26%
Quick Ratio 24% %
Debt-to-equity -404% % -239%
Return On Equity 9% %
Return On Assets -3% % -99%
Operating Margin -1% % 74%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $7,988,383 USD -58%
Weighted Average Number of Shares Outstanding, Basic 13,717,309 shares 105%
Weighted Average Number of Shares Outstanding, Diluted 37,504,811 shares 461%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,759,484,000 USD 38%
Cost of Revenue $1,641,638,000 USD 37%
General and Administrative Expense $133,937,000 USD 33%
Costs and Expenses $1,776,913,000 USD 34%
Operating Income (Loss) $17,429,000 USD 65%
Income Tax Expense (Benefit) $2,498,000 USD 551%
Net Income (Loss) Attributable to Parent $10,123,000 USD 78%
Earnings Per Share, Basic -1 USD/shares 49%
Earnings Per Share, Diluted -1 USD/shares 35%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $62,849,000 USD 120%
Accounts Receivable, after Allowance for Credit Loss, Current $129,233,000 USD 0.06%
Inventory, Net $60,712,000 USD 36%
Assets, Current $331,472,000 USD 19%
Deferred Income Tax Assets, Net $0 USD -100%
Operating Lease, Right-of-Use Asset $50,157,000 USD 16%
Intangible Assets, Net (Excluding Goodwill) $2,476,000 USD 1276%
Goodwill $10,900,000 USD 938%
Other Assets, Noncurrent $25,584,000 USD 237%
Assets $470,328,000 USD 26%
Accounts Payable, Current $170,736,000 USD 34%
Employee-related Liabilities, Current $16,725,000 USD 47%
Liabilities, Current $216,847,000 USD 28%
Operating Lease, Liability, Noncurrent $48,018,000 USD 21%
Other Liabilities, Noncurrent $10,333,000 USD -27%
Liabilities $362,321,000 USD 19%
Accumulated Other Comprehensive Income (Loss), Net of Tax $28,000 USD -65%
Retained Earnings (Accumulated Deficit) $102,171,000 USD 37%
Stockholders' Equity Attributable to Parent $46,215,000 USD 71%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $44,631,000 USD 72%
Liabilities and Equity $470,328,000 USD 26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $45,137,000 USD
Net Cash Provided by (Used in) Financing Activities $254,000 USD -142%
Net Cash Provided by (Used in) Investing Activities $1,522,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $46,405,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $62,849,000 USD 120%
Deferred Tax Assets, Valuation Allowance $32,611,000 USD 87%
Deferred Tax Assets, Gross $32,611,000 USD 60%
Operating Lease, Liability $55,232,000 USD 19%
Payments to Acquire Property, Plant, and Equipment $4,132,000 USD 49%
Lessee, Operating Lease, Liability, to be Paid $72,392,000 USD 20%
Operating Lease, Liability, Current $7,214,000 USD 7.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two $11,930,000 USD 24%
Lessee, Operating Lease, Liability, to be Paid, Year One $10,746,000 USD 14%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $17,160,000 USD 23%
Lessee, Operating Lease, Liability, to be Paid, Year Three $10,597,000 USD 15%
Deferred Tax Assets, Operating Loss Carryforwards $13,680,000 USD 36%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $8,273,000 USD 2.9%
Operating Lease, Payments $2,799,000 USD -1.6%
Additional Paid in Capital $56,292,000 USD
Depreciation, Depletion and Amortization $2,506,000 USD 14%
Deferred Tax Assets, Net of Valuation Allowance $0 USD -100%
Interest Expense $1,763,000 USD 24%